- Home
- ANL vs SY Comparison
ANL vs SY Comparison
Compare ANL & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- SY
- Stock Information
- Founded
- ANL 2004
- SY 2013
- Country
- ANL Cayman Islands
- SY China
- Employees
- ANL N/A
- SY N/A
- Industry
- ANL
- SY EDP Services
- Sector
- ANL
- SY Technology
- Exchange
- ANL Nasdaq
- SY Nasdaq
- Market Cap
- ANL 79.0M
- SY 88.7M
- IPO Year
- ANL 2023
- SY 2019
- Fundamental
- Price
- ANL $2.05
- SY $0.93
- Analyst Decision
- ANL Strong Buy
- SY Hold
- Analyst Count
- ANL 2
- SY 1
- Target Price
- ANL $9.00
- SY $0.80
- AVG Volume (30 Days)
- ANL 13.8K
- SY 43.6K
- Earning Date
- ANL 02-24-2025
- SY 11-20-2024
- Dividend Yield
- ANL N/A
- SY N/A
- EPS Growth
- ANL N/A
- SY 1.45
- EPS
- ANL N/A
- SY 0.05
- Revenue
- ANL $5,000,000.00
- SY $212,139,568.00
- Revenue This Year
- ANL N/A
- SY $2.13
- Revenue Next Year
- ANL N/A
- SY $4.64
- P/E Ratio
- ANL N/A
- SY $18.90
- Revenue Growth
- ANL N/A
- SY 3.87
- 52 Week Low
- ANL $1.85
- SY $0.66
- 52 Week High
- ANL $17.48
- SY $1.42
- Technical
- Relative Strength Index (RSI)
- ANL 44.92
- SY 59.84
- Support Level
- ANL $2.00
- SY $0.89
- Resistance Level
- ANL $2.19
- SY $0.96
- Average True Range (ATR)
- ANL 0.27
- SY 0.05
- MACD
- ANL -0.01
- SY 0.01
- Stochastic Oscillator
- ANL 16.81
- SY 86.49
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About SY So-Young International Inc. American Depository Shares
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenues from information services fees and reservation services fees from medical aesthetic service providers.